Publishing research using ab50582? Please let us know so that we can cite the reference in this datasheet.

ab50582 has been referenced in 1 publication.

  • Chua HH  et al. TSG?154-1054 splice variant increases TSG101 oncogenicity by inhibiting its E3-ligase-mediated proteasomal degradation. Oncotarget 7:8240-52 (2016). WB . PubMed: 26811492

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up